Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Permian Resources Corp (Class A) | William M Hickey | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 9,277,692 | 10,287,828 (3%) | 3% | - | Class A Common Stock | |
| Permian Resources Corp (Class A) | William M Hickey | Director, Co-Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 9,277,692 | 0 | - | - | Common Units | |
| Permian Resources Corp (Class A) | James H. Walter | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 9,052,692 | 10,062,830 (3%) | 3% | - | Class A Common Stock | |
| Permian Resources Corp (Class A) | James H. Walter | Director, Co-Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 9,052,692 | 0 | - | - | Common Units | |
| Inhibikase Therapeutics Inc | Mark T. Iwicki | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 4,982,706 | 4,982,706 | - | - | Stock Option (Right to Buy) | |
| Permian Resources Corp (Class A) | James H. Walter | Director, Co-Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 2,989,989 | 0 | - | - | Common Units | |
| Permian Resources Corp (Class A) | James H. Walter | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 2,989,989 | 2,989,989 (1%) | 1% | - | Class A Common Stock | |
| Permian Resources Corp (Class A) | William M Hickey | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 2,989,989 | 2,989,989 (1%) | 1% | - | Class A Common Stock | |
| Permian Resources Corp (Class A) | William M Hickey | Director, Co-Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 2,989,989 | 0 | - | - | Common Units | |
| Warner Bros. (Class A) | David M. Zaslav | Director, Chief Executive Officer & Pres | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 1,963,465 | 8,681,017 (5%) | 1% | 0 | Series A Common Stock | |
| XTI Aerospace Inc | Tobin Arthur | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 1,512,200 | 1,512,200 | - | - | Stock Option (Right to Buy Common Stock) | |
| Permian Resources Corp (Class A) | John Charles Bell | EVP, General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 1,353,243 | 0 | - | - | Common Units | |
| Permian Resources Corp (Class A) | John Charles Bell | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 1,353,243 | 1,729,685 (0%) | 0% | - | Class A Common Stock | |
| Snap Inc (Class A) | Evan T. Spiegel | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 05 Jan 2026 | 1,220,165 | 25,851,352 (2%) | 0% | 8.2 | 10,066,361 | Class A Common Stock |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 1,000,000 | 0 | - | - | Common Units | |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 1,000,000 | 1,360,667 (0%) | 0% | - | Class A Common Stock | |
| Inhibikase Therapeutics Inc | David McIntyre | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 986,319 | 986,319 | - | - | Stock Option (Right to Buy) | |
| Latham Grp Inc | Sean Gadd | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 907,591 | 907,591 | - | - | Stock Appreciation Right | |
| Inhibikase Therapeutics Inc | Christopher Cabell | President & Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 900,117 | 900,117 | - | - | Stock Option (Right to Buy) | |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 731,330 | 2,522,825 | - | - | Employee Stock Option (right to buy) | |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.09 per share. | 05 Jan 2026 | 731,330 | 2,725,233 | - | 1.1 | 797,150 | Common Stock |
| Kopin Corp | Michael Andrew Murray | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 724,638 | 1,316,004 | - | - | Common Stock (right to buy) | |
| Affirm Holdings Inc (Class A) | Max R. Levchin | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.00 per share. | 05 Jan 2026 | 666,666 | 666,666 | - | 49 | 32,666,634 | Class A Common Stock |
| Affirm Holdings Inc (Class A) | Max R. Levchin | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 666,666 | 10,500,002 | - | - | Performance Based Stock Options | |
| BioVie Inc | Cuong Viet Do | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 665,300 | 665,300 | - | - | Stock Option (right to buy) | |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 05 Jan 2026 | 632,874 | 5,681,249 | - | 4.4 | 2,803,632 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 05 Jan 2026 | 632,874 | 5,048,375 | - | 4.4 | 2,816,289 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 05 Jan 2026 | 632,874 | 4,415,501 | - | 4.7 | 2,974,508 | Class A Common Stock |
| Lumen Tech Inc | James Fowler | EVP, Chief Tech & Product Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 612,860 | 1,048,310 (0%) | 0% | 0 | Common Stock | |
| Kopin Corp | Michael Andrew Murray | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 583,658 | 3,157,789 (3%) | 0% | 0 | Common Stock | |
| Affirm Holdings Inc (Class A) | Max R. Levchin | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.52 per share. | 05 Jan 2026 | 553,554 | 113,112 | - | 80.5 | 44,572,168 | Class A Common Stock |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 500,000 | 0 | - | - | Common Units | |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 500,000 | 500,000 (0%) | 0% | - | Class A Common Stock | |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 500,000 | 500,000 (0%) | 0% | - | Class A Common Stock | |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 500,000 | 0 | - | - | Common Units | |
| Permian Resources Corp (Class A) | William M Hickey | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 05 Jan 2026 | 467,725 | 1,010,136 (0%) | 0% | 13.6 | 6,375,092 | Class A Common Stock |
| Permian Resources Corp (Class A) | James H. Walter | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 05 Jan 2026 | 467,700 | 1,010,138 (0%) | 0% | 13.6 | 6,374,751 | Class A Common Stock |
| fuboTV Inc | David Gandler | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 434,890 | 731,707 | - | - | Class A Common Stock | |
| fuboTV Inc | David Gandler | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 434,890 | 869,912 | - | - | Restricted Stock Units | |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 05 Jan 2026 | 375,000 | 375,000 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 05 Jan 2026 | 375,000 | 49,044,572 | - | - | Class B Common Stock | ||
| Snap Inc (Class A) | Evan T. Spiegel | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2026 | 364,078 | 25,487,274 (2%) | 0% | 0 | Class A Common Stock | |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 362,644 | 186,538 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 350,000 | 350,000 | - | - | Employee Stock Option | |
| BioVie Inc | Michael E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 341,100 | 341,100 | - | - | Stock Option (right to buy) | |
| BioVie Inc | James Paul Lang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 330,500 | 330,500 | - | - | Stock Option (right to buy) | |
| Permian Resources Corp (Class A) | James H. Walter | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.74 per share. | 05 Jan 2026 | 310,003 | 1,477,838 (0%) | 0% | 13.7 | 4,259,441 | Class A Common Stock |
| Permian Resources Corp (Class A) | William M Hickey | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.74 per share. | 05 Jan 2026 | 309,980 | 1,477,861 (0%) | 0% | 13.7 | 4,259,125 | Class A Common Stock |
| Actuate Therapeutics Inc | Todd S. Thomson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.80 per share. | 05 Jan 2026 | 280,000 | 904,795 | - | 5.8 | 1,624,000 | Common Stock |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 74.02 per share. | 05 Jan 2026 | 252,046 | 2,263,444 | - | 74.0 | 18,655,840 | Common Stock |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.04 per share. | 05 Jan 2026 | 241,629 | 1,359,568 | - | 78.0 | 18,857,573 | Common Stock |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 239,900 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.29 per share. | 05 Jan 2026 | 239,900 | 254,350 (0%) | 0% | 83.3 | 19,981,271 | Common Stock |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.99 per share. | 05 Jan 2026 | 236,951 | 1,601,197 | - | 77.0 | 18,241,673 | Common Stock |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 74.91 per share. | 05 Jan 2026 | 234,588 | 2,028,856 | - | 74.9 | 17,572,799 | Common Stock |
| Definitive Healthcare Corp (Class A) | Casey Heller | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 195,313 | 1,275,490 | - | 0 | Class A Common Stock | |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.97 per share. | 05 Jan 2026 | 190,708 | 1,838,148 | - | 76.0 | 14,488,678 | Common Stock |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 185,276 | 478,551 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 73.03 per share. | 05 Jan 2026 | 185,066 | 2,515,490 | - | 73.0 | 13,515,296 | Common Stock |
| Anixa Biosciences Inc | Michael J. Catelani | President, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 175,000 | 175,000 | - | - | Employee Stock Option | |
| Permian Resources Corp (Class A) | Guy M. Oliphint | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 05 Jan 2026 | 172,904 | 616,683 (0%) | 0% | 13.6 | 2,356,682 | Class A Common Stock |
| fuboTV Inc | David Gandler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 05 Jan 2026 | 170,279 | 561,428 | - | 2.6 | 434,722 | Class A Common Stock |
| Hinge Health Inc (Class A) | Daniel Perez | Director, CEO & Co-Founder, Ten Percent Owner | 05 Jan 2026 | 166,665 | 166,665 | - | 0 | Class A Common Stock | ||
| Hinge Health Inc (Class A) | Daniel Perez | Director, CEO & Co-Founder, Ten Percent Owner | 05 Jan 2026 | 166,665 | 14,376,762 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 11.28 per share. | 05 Jan 2026 | 166,440 | 1,251,383 | - | 11.3 | 1,877,110 | Class A Common Stock |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 05 Jan 2026 | 166,440 | 1,417,823 | - | 0 | Class A Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 05 Jan 2026 | 166,440 | 7,861,138 | - | - | Class B Common Stock | ||
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | 05 Jan 2026 | 164,870 | 164,870 | - | 0 | Class A Common Stock | ||
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | Sale of securities on an exchange or to another person at price $ 12.79 per share. | 05 Jan 2026 | 164,870 | 0 | - | 12.8 | 2,108,687 | Class A Common Stock |
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | 05 Jan 2026 | 164,870 | 961,693 | - | - | The Hagerty Group, LLC Units | ||
| Intellia Therapeutics Inc | Fred E. Cohen | Director | Purchase of securities on an exchange or from another person at price $ 9.35 per share. | 05 Jan 2026 | 150,000 | 207,453 (0%) | 0% | 9.4 | 1,402,500 | Common Stock |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 122.46 per share. | 05 Jan 2026 | 146,760 | 72,474 | - | 122.5 | 17,971,980 | Class A Common Stock |
| Thryv Holdings Inc | Joseph A. Walsh | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 144,578 | 736,084 | - | 0 | Common Shares | |
| BioVie Inc | Sigmund Rogich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 141,100 | 141,100 | - | - | Stock Option (right to buy) | |
| UL Soln Inc (Class A) | Ryan D. Robinson | Executive VP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2026 | 135,956 | 135,956 | - | 0 | Class A Common Stock | |
| UL Soln Inc (Class A) | Ryan D. Robinson | Executive VP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2026 | 135,956 | 1,000 | - | 0 | Class A Common Stock | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 162.54 per share. | 05 Jan 2026 | 134,540 | 152,700 (0%) | 0% | 162.5 | 21,868,387 | Common Stock |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 132,000 | 132,000 | - | - | Stock Option (right to buy) | |
| Permian Resources Corp (Class A) | Guy M. Oliphint | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.76 per share. | 05 Jan 2026 | 128,837 | 789,587 (0%) | 0% | 13.8 | 1,772,797 | Class A Common Stock |
| Adaptive biotech Corp | Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 15.59 per share. | 05 Jan 2026 | 124,998 | 2,584,243 (2%) | 0% | 15.6 | 1,948,719 | Common Stock |
| Connexa Sports Tech Inc | Hongyu Zhou | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 05 Jan 2026 | 123,088 | 302,470 | - | 1.0 | 125,550 | Common Stock |
| Hinge Health Inc (Class A) | Daniel Perez | Director, CEO & Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.25 per share. | 05 Jan 2026 | 122,368 | 44,297 | - | 46.2 | 5,659,006 | Class A Common Stock |
| Thryv Holdings Inc | Paul D. Rouse | CFO, Executive VP & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 120,481 | 306,836 | - | 0 | Common Shares | |
| Thryv Holdings Inc | Grant Freeman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 120,481 | 256,433 | - | 0 | Common Shares | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,402,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,642,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,522,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,522,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,402,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,642,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,642,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,522,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 13,402,396 (19%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 05 Jan 2026 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Bloomin Brands Inc | Patrick Hafner | EVP, Pres Outback Steakhouse | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 115,741 | 115,741 | - | - | Restricted Stock Units | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 115,000 | 115,000 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Johannes Jacob Pieter Kastelein | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 115,000 | 115,000 | - | - | Option (right to buy) | |
| Affirm Holdings Inc (Class A) | Max R. Levchin | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.12 per share. | 05 Jan 2026 | 113,112 | 0 | - | 81.1 | 9,175,645 | Class A Common Stock |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 110,100 | 110,100 | - | - | Stock Option (right to buy) | |
| Easterly Government Properties Inc | Darrell W. Crate | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 109,265 | 109,265 | - | - | LTIP Units | |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 05 Jan 2026 | 106,405 | 360,667 (0%) | 0% | 13.6 | 1,450,300 | Class A Common Stock |
| Permian Resources Corp (Class A) | John Charles Bell | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 05 Jan 2026 | 106,399 | 376,442 (0%) | 0% | 13.6 | 1,450,218 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 05 Jan 2026 | 102,835 | 351,499 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 05 Jan 2026 | 102,835 | 8,808,650 | - | - | Class B Common Stock | ||
| Alphatec Holdings Inc | Patrick S. Miles | Director, CEO | Sale of securities on an exchange or to another person at price $ 21.01 per share. | 05 Jan 2026 | 100,000 | 5,135,398 (8%) | 0% | 21.0 | 2,101,000 | Common Stock |
| Atlantic Intl Corp | Matthew Evelt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 100,000 | 1,100,000 | - | - | Incentive Stock Options | |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.29 per share. | 05 Jan 2026 | 100,000 | 1,480,000 | - | 90.3 | 9,029,100 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.29 per share. | 05 Jan 2026 | 100,000 | 1,480,000 | - | 90.3 | 9,029,100 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.29 per share. | 05 Jan 2026 | 100,000 | 1,480,000 | - | 90.3 | 9,029,100 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.29 per share. | 05 Jan 2026 | 100,000 | 1,480,000 | - | 90.3 | 9,029,100 | Class A Common Stock |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Biosig Tech Inc | Kevin Roy Gopaul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| National Research Corp | David Burik | EVP, Strategic Insights | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| ATI Inc | Kimberly A. Fields | Director, President, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 98,620 | 313,798 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
| Equity Bancshares Inc (Class A) | Brad S. Elliott | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 92,852 | 92,852 | - | - | Stock Option (Right to Buy) | |
| Grindr Inc (Class A) | James Fu Bin Lu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.53 per share. | 05 Jan 2026 | 92,071 | 419,762 | - | 13.5 | 1,245,721 | Common Stock |
| BioVie Inc | James Paul Lang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Crown Holdings Inc | Timothy J. Donahue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 85,386 | 489,736 (0%) | 0% | 0 | Common | |
| Thryv Holdings Inc | John F. Wholey | Executive VP of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 84,337 | 298,020 | - | 0 | Common Stock | |
| Thryv Holdings Inc | Lesley Bolger | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 84,337 | 201,089 | - | 0 | Common Stock | |
| Cleveland-Cliffs Inc | C. Lourenco Goncalves | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 05 Jan 2026 | 84,229 | 3,015,486 (1%) | 0% | 13.2 | 1,111,823 | Common Shares |
| CIENA Corp | Gary B. Smith | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 229.44 per share. | 05 Jan 2026 | 83,552 | 307,885 (0%) | 0% | 229.4 | 19,170,163 | Common Stock |
| Sui Grp Holdings Ltd | Brian David Quintenz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 83,026 | 83,026 | - | - | Warrant for Common Stock | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 163.61 per share. | 05 Jan 2026 | 82,934 | 69,766 (0%) | 0% | 163.6 | 13,568,633 | Common Stock |
| ATI Inc | Kimberly A. Fields | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 82,216 | 357,143 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 80,800 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.24 per share. | 05 Jan 2026 | 80,800 | 335,150 (0%) | 0% | 117.2 | 9,472,992 | Common Stock |
| BioVie Inc | Michael E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.02 per share. | 05 Jan 2026 | 78,703 | 85,932 (0%) | 0% | 8.0 | 631,198 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 171.28 per share. | 05 Jan 2026 | 78,703 | 7,229 (0%) | 0% | 171.3 | 13,480,250 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 78,703 | 93,121 | - | - | Stock Option (Right to Buy) | |
| SSR Mining Inc | Rodney P. Antal | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 73,129 | 73,129 | - | - | Performance Share Units | |
| SSR Mining Inc | Rodney P. Antal | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 73,129 | 1,351,963 (1%) | 0% | 0 | Common Shares | |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.08 per share. | 05 Jan 2026 | 72,907 | 405,644 (0%) | 0% | 121.1 | 8,827,580 | Common Stock, par value $0.10 per share |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.11 per share. | 05 Jan 2026 | 72,474 | 0 | - | 123.1 | 8,922,542 | Class A Common Stock |
| Kopin Corp | Paul Baker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 72,000 | 596,865 (0%) | 0% | 0 | Common Stock | |
| ATI Inc | Timothy J. Harris | Senior VP and CDIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 70,442 | 171,429 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
| Permian Resources Corp (Class A) | Robert Regan Shannon | EVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.76 per share. | 05 Jan 2026 | 70,254 | 467,072 (0%) | 0% | 13.8 | 966,695 | Class A Common Stock |
| Permian Resources Corp (Class A) | John Charles Bell | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 13.76 per share. | 05 Jan 2026 | 70,249 | 482,841 (0%) | 0% | 13.8 | 966,626 | Class A Common Stock |
| Beyond Air Inc | Daniel J. Moorhead | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Sigmund Rogich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.08 per share. | 05 Jan 2026 | 69,369 | 293,275 (0%) | 0% | 121.1 | 8,399,199 | Common Stock, par value $0.10 per share |
| Camden Property - REIT | Richard J. Campo | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 67,129 | 72,267 | - | - | Option to Repurchase | |
| Camden Property - REIT | Richard J. Campo | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.71 per share. | 05 Jan 2026 | 67,129 | 339,177 (0%) | 0% | 10.7 | 719,086 | Common Shares |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 66,666 | 66,668 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 66,666 | 224,952 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | John P. Shannon | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.55 per share. | 05 Jan 2026 | 64,265 | 2,769,611 (10%) | 0% | 1.6 | 99,611 | Common Stock |
| Xeris Biopharma Holdings Inc | John P. Shannon | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 64,265 | 0 | - | - | Stock Option (Right to Buy) | |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 64,103 | 64,102 | - | - | Performance Stock Unit | |
| Equity Bancshares Inc (Class A) | Richard M. Sems | Chief Executive Officer, Bank | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 61,901 | 61,901 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | 05 Jan 2026 | 60,000 | 973,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | 05 Jan 2026 | 60,000 | 4,663,334 | - | - | Class B Common Stock | ||
| Toast Inc (Class A) | Jonathan Vassil | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 58,610 | 328,751 | - | - | Stock Option (Right to Buy) | |
| Toast Inc (Class A) | Jonathan Vassil | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.21 per share. | 05 Jan 2026 | 58,610 | 138,412 | - | 2.2 | 129,528 | Class A Common Stock |
| BioVie Inc | Amy S. Chappell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 57,500 | 57,500 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Kameel D. Farag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 57,500 | 57,500 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Joel Lewis | Director, President and CEO | 05 Jan 2026 | 56,332 | 776,260 (1%) | 0% | 3.9 | 218,568 | Common Stock | |
| PB Bankshares Inc | Janak M. Amin | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 55,404 | 0 | - | - | Common Stock | |
| PB Bankshares Inc | Janak M. Amin | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 55,097 | 0 | - | - | Common Stock | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 53,500 | 53,500 | - | - | Option (right to buy) | |
| Hayward Holdings Inc | Kevin P. Holleran | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. | 05 Jan 2026 | 52,390 | 675,930 | - | 1.4 | 73,346 | Common Stock |
| Hayward Holdings Inc | Kevin P. Holleran | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.99 per share. | 05 Jan 2026 | 52,390 | 623,540 | - | 16.0 | 837,899 | Common Stock |
| Hayward Holdings Inc | Kevin P. Holleran | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 52,390 | 2,462,181 | - | - | Stock Options (Right to Buy) | |
| PB Bankshares Inc | Joseph W. Carroll | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 50,795 | 0 | - | - | Common Stock | |
| Capricor Therapeutics Inc | Frank Litvack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| 10x Genomics Inc (Class A) | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 05 Jan 2026 | 50,000 | 1,071,556 (5%) | 0% | 1.2 | 60,000 | Class A Common Stock |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 121.62 per share. | 05 Jan 2026 | 49,521 | 219,234 | - | 121.6 | 6,022,947 | Class A Common Stock |
| Easterly Government Properties Inc | Michael P. Ibe | Director, EVP - Dev & Acquisitions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 48,749 | 48,749 | - | - | LTIP Units | |
| Easterly Government Properties Inc | Darrell W. Crate | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 48,685 | 48,685 | - | - | LTIP Units | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 161.12 per share. | 05 Jan 2026 | 47,910 | 287,240 (0%) | 0% | 161.1 | 7,719,216 | Common Stock |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 47,668 | 0 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 47,668 | 180,943 (0%) | 0% | 0 | Common Stock | |
| ATI Inc | Timothy J. Harris | Senior VP and CDIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 46,318 | 186,829 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
| Bloomin Brands Inc | Kelly M. Lefferts | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 46,297 | 46,297 | - | - | Restricted Stock Units | |
| Nuvalent Inc (Class A) | James R. Porter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 46,250 | 324,879 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | James R. Porter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 05 Jan 2026 | 45,000 | 28,388,585 | - | 15.7 | 707,931 | Class A Commmon Stock |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 05 Jan 2026 | 44,922 | 44,922 | - | 0 | Class A Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | 05 Jan 2026 | 44,922 | 1,483,941 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 11.28 per share. | 05 Jan 2026 | 44,922 | 0 | - | 11.3 | 506,635 | Class A Common Stock |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 120.13 per share. | 05 Jan 2026 | 44,893 | 268,755 | - | 120.1 | 5,393,162 | Class A Common Stock |
| Hinge Health Inc (Class A) | Daniel Perez | Director, CEO & Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.77 per share. | 05 Jan 2026 | 44,297 | 0 | - | 46.8 | 2,071,611 | Class A Common Stock |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 42,640 | 42,640 (0%) | 0% | 0 | Common stock, par value $0.001 | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.10 per share. | 05 Jan 2026 | 42,544 | 0 (0%) | 0% | 17.1 | 727,319 | Common Stock |
| Movano Inc | Michael Leabman | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 42,250 | 0 | - | - | Stock Options (Right to Buy) | |
| Movano Inc | Michael Leabman | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 05 Jan 2026 | 42,250 | 42,606 | - | 1.3 | 52,813 | Common Stock |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 42,105 | 281,843 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 42,105 | 2,618,539 | - | - | Restricted Stock Units | |
| Sui Grp Holdings Ltd | Brian David Quintenz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 41,513 | 41,513 | - | - | Warrant for Common Stock | |
| Sui Grp Holdings Ltd | Brian David Quintenz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 41,513 | 41,513 | - | - | Warrant for Common Stock | |
| Sui Grp Holdings Ltd | Brian David Quintenz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 41,513 | 41,513 | - | - | Warrant for Common Stock | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 05 Jan 2026 | 40,761 | 2,413,158 | - | 0.7 | 26,495 | Common Stock |
| Kimco Realty - REIT | Philip E. Coviello | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2026 | 40,123 | 40,942 (0%) | 0% | 0 | Common Stock | |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.70 per share. | 05 Jan 2026 | 40,000 | 1,876,980 (6%) | 0% | 6.7 | 267,988 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.70 per share. | 05 Jan 2026 | 40,000 | 1,876,980 (6%) | 0% | 6.7 | 267,988 | Common Stock |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.27 per share. | 05 Jan 2026 | 40,000 | 2,690,579 (3%) | 0% | 10.3 | 410,800 | Class A Common Stock |
| PharmaCyte Biotech Inc | Joshua Nathaniel Silverman | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 05 Jan 2026 | 40,000 | 416,250 | - | 0.8 | 33,316 | Common Stock |
| Perpetua Resources Corp | Mckinsey Margaret Lyon | (See remarks (4)) | 05 Jan 2026 | 40,000 | 129,154 | - | 8.6 | 343,600 | Common Shares | |
| Perpetua Resources Corp | Mckinsey Margaret Lyon | (See remarks (4)) | 05 Jan 2026 | 40,000 | 0 | - | - | Director and Employee Stock Option (right to buy) | ||
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.71 per share. | 05 Jan 2026 | 40,000 | 40,000 | - | 18.7 | 748,400 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 40,000 | 2,553,924 | - | - | Employee Stock Option (right to buy) | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | Sale of securities on an exchange or to another person at price $ 4.25 per share. | 05 Jan 2026 | 40,000 | 933,839 | - | 4.3 | 170,000 | Class A Common Stock |
| StandardAero Inc | Russell Wayne Ford | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.18 per share. | 05 Jan 2026 | 40,000 | 966,955 | - | 30.2 | 1,207,336 | Common Stock |
| StandardAero Inc | Russell Wayne Ford | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.46 per share. | 05 Jan 2026 | 40,000 | 926,955 | - | 30.5 | 1,218,404 | Common Stock |
| Natera Inc | Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.59 per share. | 05 Jan 2026 | 39,615 | 262,581 (0%) | 0% | 9.6 | 379,908 | Common Stock |
| Natera Inc | Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 39,615 | 0 | - | - | Stock Option (right to buy) | |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 119.31 per share. | 05 Jan 2026 | 39,197 | 313,648 | - | 119.3 | 4,676,524 | Class A Common Stock |
| ATI Inc | Kimberly A. Fields | Director, President, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.08 per share. | 05 Jan 2026 | 38,871 | 274,927 (0%) | 0% | 121.1 | 4,706,501 | Common Stock, par value $0.10 per share |
| SSR Mining Inc | Rodney P. Antal | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.02 per share. | 05 Jan 2026 | 38,460 | 1,278,834 (1%) | 0% | 21.0 | 808,429 | Common Shares |
| CF Industries | Christopher D. Bohn | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 38,437 | 201,565 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Acumen Pharma Inc | Daniel O'Connell | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.99 per share. | 05 Jan 2026 | 37,755 | 619,982 | - | 2.0 | 74,981 | Common Stock |
| Spok Holdings Inc | Vincent D. Kelly | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.19 per share. | 05 Jan 2026 | 37,430 | 140,247 (0%) | 0% | 13.2 | 493,702 | Common Stock |
| Utz Brands Inc (Class A) | William J. Kelley | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 37,281 | 51,039 | - | 0 | Class A Common Stock | |
| Acadia Realty Trust | David E. Buell | SVP, Chief Accounting Officer. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 36,684 | 36,684 | - | - | LTIP Units | |
| Butterfly Network Inc (Class A) | Victor Ku | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.82 per share. | 05 Jan 2026 | 35,968 | 811,962 | - | 3.8 | 137,398 | Class A Common Stock |
| ATI Inc | Kimberly A. Fields | Director, President, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 35,898 | 35,897 | - | - | Performance Stock Unit | |
| Ironwood Pharma Inc (Class A) | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 05 Jan 2026 | 35,416 | 276,809 (0%) | 0% | 4.6 | 162,914 | Class A Common Stock |
| Crown Holdings Inc | Timothy J. Donahue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.74 per share. | 05 Jan 2026 | 34,336 | 404,350 (0%) | 0% | 105.7 | 3,630,689 | Common |
| Liveperson Inc | John D. Collins | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 34,193 | 116,007 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | John M. Leonard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.21 per share. | 05 Jan 2026 | 34,146 | 1,013,339 (2%) | 0% | 9.2 | 314,485 | Common Stock |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.61 per share. | 05 Jan 2026 | 34,000 | 1,910,980 (6%) | 0% | 6.6 | 224,886 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.61 per share. | 05 Jan 2026 | 34,000 | 1,910,980 (6%) | 0% | 6.6 | 224,886 | Common Stock |
| 10x Genomics Inc (Class A) | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 32,537 | 173,600 | - | - | Stock Option (right to buy) | |
| Perpetua Resources Corp | Mckinsey Margaret Lyon | (See remarks (4)) | Sale of securities on an exchange or to another person at price $ 26.61 per share. | 05 Jan 2026 | 32,490 | 96,664 | - | 26.6 | 864,559 | Common Shares |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 05 Jan 2026 | 32,418 | 344,564 (0%) | 0% | 0 | Class A Common Stock | ||
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 05 Jan 2026 | 32,418 | 2,642,200 | - | - | Class B Common Stock | ||
| ATI Inc | Kimberly A. Fields | Director, President, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.08 per share. | 05 Jan 2026 | 32,352 | 324,791 (0%) | 0% | 121.1 | 3,917,180 | Common Stock, par value $0.10 per share |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 05 Jan 2026 | 31,686 | 193,266 (0%) | 0% | 25.1 | 795,220 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.02 per share. | 05 Jan 2026 | 31,261 | 38,490 (0%) | 0% | 8.0 | 250,713 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 170.38 per share. | 05 Jan 2026 | 31,261 | 7,229 (0%) | 0% | 170.4 | 5,326,249 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 31,261 | 32,410 | - | - | Stock Option (Right to Buy) | |
| ATI Inc | Timothy J. Harris | Senior VP and CDIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.08 per share. | 05 Jan 2026 | 30,918 | 140,511 (0%) | 0% | 121.1 | 3,743,551 | Common Stock, par value $0.10 per share |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 164.58 per share. | 05 Jan 2026 | 30,244 | 39,522 (0%) | 0% | 164.6 | 4,977,530 | Common Stock |
| PharmaCyte Biotech Inc | Joshua Nathaniel Silverman | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 05 Jan 2026 | 30,000 | 346,250 | - | 0.8 | 23,493 | Common Stock |
| PharmaCyte Biotech Inc | Joshua Nathaniel Silverman | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 05 Jan 2026 | 30,000 | 376,250 | - | 0.8 | 23,667 | Common Stock |
| Arcus Biosciences Inc | Juan Carlos Jaen | President | Sale of securities on an exchange or to another person at price $ 21.34 per share. | 05 Jan 2026 | 29,670 | 924,393 (2%) | 0% | 21.3 | 633,158 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.02 per share. | 05 Jan 2026 | 29,450 | 36,679 (0%) | 0% | 8.0 | 236,189 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 172.33 per share. | 05 Jan 2026 | 29,450 | 7,229 (0%) | 0% | 172.3 | 5,075,119 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 29,450 | 63,671 | - | - | Stock Option (Right to Buy) | |
| Esquire Fin Holdings Inc | Andrew C. Sagliocca | Director, Vice Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 05 Jan 2026 | 29,250 | 294,172 (3%) | 0% | 12.5 | 365,625 | Common Stock |
| Esquire Fin Holdings Inc | Andrew C. Sagliocca | Director, Vice Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 29,250 | 0 | - | - | Stock Options | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.26 per share. | 05 Jan 2026 | 29,250 | 42,544 (0%) | 0% | 8.3 | 241,605 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 29,250 | 87,750 | - | - | Stock Option (Right to Buy) | |
| Crown Holdings Inc | Timothy J. Donahue | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 05 Jan 2026 | 29,024 | 411,556 (0%) | 0% | 105 | 3,047,520 | Common |
| Sun Communities Inc | Mark Patten | EVP, CFO, Sec. & Treas. | Grant, award, or other acquisition of securities at price $ 121.14 per share. | 05 Jan 2026 | 28,892 | 28,892 (0%) | 0% | 121.1 | 3,499,977 | COMMON STOCK, $0.01 PAR VALUE |
| Chevron | Eimear P. Bonner | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 165.05 per share. | 05 Jan 2026 | 28,334 | 4,366 (0%) | 0% | 165.1 | 4,676,527 | Common Stock |
| Chevron | Eimear P. Bonner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 28,334 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | Eimear P. Bonner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.20 per share. | 05 Jan 2026 | 28,334 | 32,700 (0%) | 0% | 88.2 | 2,499,059 | Common Stock |
| Avnet Inc | Philip R. Gallagher | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.04 per share. | 05 Jan 2026 | 27,986 | 168,923 (0%) | 0% | 49.0 | 1,372,433 | Common Stock |
| Corvel Corp | Michael G. Combs | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.00 per share. | 05 Jan 2026 | 27,750 | 72,075 (0%) | 0% | 52.0 | 1,442,917 | Common Stock |
| Corvel Corp | Michael G. Combs | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 27,750 | 22,871 | - | - | Non-Qualified Stock Option (right to buy) | |
| Crown Holdings Inc | Timothy J. Donahue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 27,130 | 438,686 (0%) | 0% | 0 | Common | |
| QuantumScape Corp (Class A) | Jeffrey B. Straubel | Director | Sale of securities on an exchange or to another person at price $ 11.28 per share. | 05 Jan 2026 | 27,106 | 239,722 | - | 11.3 | 305,691 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 78.18 per share. | 05 Jan 2026 | 25,729 | 302,878 | - | 78.2 | 2,011,529 | Class A Common Stock |
| ATI Inc | Timothy J. Harris | Senior VP and CDIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 25,641 | 25,641 | - | - | Performance Stock Unit | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,500 | 58,382 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | Johannes Jacob Pieter Kastelein | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,500 | 98,981 | - | - | Ordinary Shares | |
| Everspin Tech Inc | Sanjeev Aggarwal | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.22 per share. | 05 Jan 2026 | 25,345 | 549,412 (3%) | 0% | 10.2 | 259,026 | Common Stock |
| PENN Entertainment Inc | David A. Handler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,253 | 388,194 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | John P. Shannon | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.55 per share. | 05 Jan 2026 | 25,136 | 2,794,747 (10%) | 0% | 1.6 | 38,961 | Common Stock |
| Xeris Biopharma Holdings Inc | John P. Shannon | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 25,136 | 0 | - | - | Stock Option (Right to Buy) | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 165.05 per share. | 05 Jan 2026 | 25,072 | 14,450 (0%) | 0% | 165.1 | 4,138,211 | Common Stock |
| Summit Hotel Properties Inc | Mehulkumar Bhikhubhai Patel | Director | Sale of securities on an exchange or to another person at price $ 4.84 per share. | 05 Jan 2026 | 25,000 | 444,295 (0%) | 0% | 4.8 | 121,000 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Arnold Baskies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Capricor Therapeutics Inc | Anthony J. Bergmann | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Anthony J. Bergmann | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 05 Jan 2026 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 05 Jan 2026 | 25,000 | 5,850,000 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 05 Jan 2026 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 05 Jan 2026 | 25,000 | 4,116,020 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 80.31 per share. | 05 Jan 2026 | 24,951 | 268,079 | - | 80.3 | 2,003,920 | Class A Common Stock |
| Xeris Biopharma Holdings Inc | John P. Shannon | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 7.08 per share. | 05 Jan 2026 | 24,907 | 2,705,346 (9%) | 0% | 7.1 | 176,257 | Common Stock |
| Camden Property - REIT | Richard J. Campo | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 109.82 per share. | 05 Jan 2026 | 24,838 | 301,156 (0%) | 0% | 109.8 | 2,727,734 | Common Shares |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.15 per share. | 05 Jan 2026 | 24,677 | 2,700,556 | - | 72.1 | 1,780,421 | Common Stock |
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | 05 Jan 2026 | 24,247 | 24,247 | - | 0 | Class A Common Stock | ||
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | Sale of securities on an exchange or to another person at price $ 13.08 per share. | 05 Jan 2026 | 24,247 | 0 | - | 13.1 | 317,151 | Class A Common Stock |
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | 05 Jan 2026 | 24,247 | 926,563 | - | - | The Hagerty Group, LLC Units | ||
| SSR Mining Inc | Michael J. Sparks | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,809 | 308,989 (0%) | 0% | 0 | Common Shares | |
| SSR Mining Inc | Michael J. Sparks | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,809 | 23,809 | - | - | Performance Share Units | |
| SSR Mining Inc | William K. MacNevin | EVP, Ops & Sustainability | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,809 | 23,809 | - | - | Performance Share Units | |
| SSR Mining Inc | William K. MacNevin | EVP, Ops & Sustainability | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,809 | 253,817 (0%) | 0% | 0 | Common Shares | |
| Ambiq Micro Inc | Michele Kim Connors | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,759 | 23,759 | - | 0 | Common Stock | |
| Equity Bancshares Inc (Class A) | Julie A. Huber | COO and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,213 | 23,213 | - | - | Stock Option (Right to Buy) | |
| Equity Bancshares Inc (Class A) | Brett A. Reber | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,213 | 23,213 | - | - | Stock Option (Right to Buy) | |
| Equity Bancshares Inc (Class A) | Chris M. Navratil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,213 | 23,213 | - | - | Stock Option (Right to Buy) | |
| Equity Bancshares Inc (Class A) | Krzysztof P. Slupkowski | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,213 | 23,213 | - | - | Stock Option (Right to Buy) | |
| Bloomin Brands Inc | Philip Pace | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,149 | 23,149 | - | - | Restricted Stock Units | |
| SSR Mining Inc | F. Edward Farid | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,015 | 23,015 | - | - | Performance Share Units | |
| SSR Mining Inc | F. Edward Farid | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 23,015 | 269,221 (0%) | 0% | 0 | Common Shares | |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 77.47 per share. | 05 Jan 2026 | 22,892 | 328,607 | - | 77.5 | 1,773,455 | Class A Common Stock |
| Spok Holdings Inc | Michael W. Wallace | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.19 per share. | 05 Jan 2026 | 22,865 | 63,234 (0%) | 0% | 13.2 | 301,589 | Common Stock |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 05 Jan 2026 | 22,657 | 158,286 (0%) | 0% | 25.1 | 568,620 | Common Stock |
| Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Crown Holdings Inc | Kevin C. Clothier | Senior Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 22,339 | 81,567 (0%) | 0% | 0 | Common | |
| Crown Holdings Inc | Djalma Novaes | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 22,339 | 117,786 (0%) | 0% | 0 | Common | |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 118.38 per share. | 05 Jan 2026 | 22,155 | 352,845 | - | 118.4 | 2,622,605 | Class A Common Stock |
| Easterly Government Properties Inc | Allison E. Marino | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 21,908 | 21,908 | - | - | LTIP Units | |
| Global Partners LP - Unit | Eric S. Slifka | Director, Chairman, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 21,459 | 0 | - | - | Phantom Units | |
| Global Partners LP - Unit | Eric S. Slifka | Director, Chairman, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 21,459 | 21,459 (0%) | 0% | 0 | Common units representing limited partner interests | |
| Corvel Corp | Michael G. Combs | CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.14 per share. | 05 Jan 2026 | 21,175 | 50,900 (0%) | 0% | 68.1 | 1,442,865 | Common Stock |
| CarPartscom Inc | Jay K. Greyson | Director | Grant, award, or other acquisition of securities at price $ 0.55 per share. | 05 Jan 2026 | 21,019 | 426,514 (1%) | 0% | 0.5 | 11,560 | Common Stock |
| U.S. Energy Corp | Ryan L. Smith | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. | 05 Jan 2026 | 20,834 | 1,162,205 (83%) | 1% | 1.0 | 20,626 | Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.97 per share. | 05 Jan 2026 | 20,833 | 4,219,588 | - | 5.0 | 103,448 | Class A Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.83 per share. | 05 Jan 2026 | 20,833 | 4,198,755 | - | 4.8 | 100,663 | Class A Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.93 per share. | 05 Jan 2026 | 20,833 | 4,177,922 | - | 4.9 | 102,653 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 248.53 per share. | 05 Jan 2026 | 20,790 | 19,210 | - | 248.5 | 5,166,876 | Class A Common Stock |
| Mission Produce Inc | Stephen J. Barnard | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 20,526 | 193,479 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Bryan E. Giles | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 20,526 | 135,306 | - | 0 | COMMON STOCK | |
| ATI Inc | Timothy J. Harris | Senior VP and CDIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.08 per share. | 05 Jan 2026 | 20,283 | 166,546 (0%) | 0% | 121.1 | 2,455,866 | Common Stock, par value $0.10 per share |
| Easterly Government Properties Inc | Allison E. Marino | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 20,172 | 20,172 | - | - | LTIP Units | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 133.85 per share. | 05 Jan 2026 | 20,011 | 310,684 (0%) | 0% | 133.8 | 2,678,430 | Class A Common Stock |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 28,890 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 20,000 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Paul Andrew Moore | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 51,212 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Paul Andrew Moore | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 20,000 | - | - | Restricted Stock Unit | |
| Nano Nuclear Energy Inc | Diane Hare | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 05 Jan 2026 | 20,000 | 20,000 | - | 3 | 60,000 | Common Stock |
| Nano Nuclear Energy Inc | Diane Hare | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 5,000 | - | - | Stock Options | |
| Perpetua Resources Corp | Jeffrey L. Malmen | Director | 05 Jan 2026 | 20,000 | 20,000 | - | 8.6 | 171,800 | Common Shares | |
| Perpetua Resources Corp | Jeffrey L. Malmen | Director | 05 Jan 2026 | 20,000 | 0 | - | - | Director and Employee Stock Option (right to buy) | ||
| Perpetua Resources Corp | Alexander Sternhell | Director | 05 Jan 2026 | 20,000 | 20,000 | - | 8.6 | 171,800 | Common Shares | |
| Perpetua Resources Corp | Alexander Sternhell | Director | 05 Jan 2026 | 20,000 | 0 | - | - | Director and Employee Stock Option (right to buy) | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 913,839 | - | 0 | Class A Common Stock | |
| Movano Inc | Jeremy J. Cogan | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 05 Jan 2026 | 20,000 | 25,204 | - | 1.3 | 25,000 | Common Stock |
| Movano Inc | Jeremy J. Cogan | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 64,834 | - | - | Stock Options (Right to Buy) | |
| Nano Nuclear Energy Inc | Diane Hare | Director | Sale of securities on an exchange or to another person at price $ 28.70 per share. | 05 Jan 2026 | 19,850 | 150 | - | 28.7 | 569,673 | Common Stock |
| PB Bankshares Inc | Douglas L. Byers | Chief Banking Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 19,842 | 0 | - | - | Common Stock | |
| PB Bankshares Inc | R. Cheston Woolard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 19,500 | 0 | - | - | Common Stock | |
| Easterly Government Properties Inc | Michael P. Ibe | Director, EVP - Dev & Acquisitions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 19,474 | 19,474 | - | - | LTIP Units | |
| SSR Mining Inc | John Ebbett | EVP, Growth and Innovation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 19,444 | 19,444 | - | - | Performance Share Units | |
| SSR Mining Inc | John Ebbett | EVP, Growth and Innovation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 19,444 | 170,122 (0%) | 0% | 0 | Common Shares | |
| Global Partners LP - Unit | Eric S. Slifka | Director, Chairman, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 19,290 | 32,804 (0%) | 0% | 0 | Common units representing limited partner interests | |
| Global Partners LP - Unit | Eric S. Slifka | Director, Chairman, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 19,290 | 19,290 | - | - | Phantom Units | |
| Cleveland-Cliffs Inc | Clifford Smith | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 05 Jan 2026 | 19,140 | 760,529 (0%) | 0% | 13.2 | 252,648 | Common Shares |
| PB Bankshares Inc | William H. Sayre | EVP, Chief Credit/Risk Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 19,090 | 0 | - | - | Common Stock | |
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 249.41 per share. | 05 Jan 2026 | 18,923 | 287 | - | 249.4 | 4,719,638 | Class A Common Stock |
| Cleveland-Cliffs Inc | Celso L. Goncalves | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 05 Jan 2026 | 18,775 | 398,849 (0%) | 0% | 13.2 | 247,830 | Common Shares |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 18,750 | 393,750 | - | - | Stock Option (Right to Buy) | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 18,750 | 2,685,306 | - | - | Class B Common Stock | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 05 Jan 2026 | 18,378 | 2,453,919 | - | 0.6 | 11,762 | Common Stock |
| South Plains Fin Inc | Cory T. Newsom | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 18,031 | 18,031 | - | - | Stock Options (Right to Buy) | |
| Transdigm Group | Kevin M. Stein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 17,940 | 20,000 | - | - | Stock Option | |
| Transdigm Group | Kevin M. Stein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.88 per share. | 05 Jan 2026 | 17,940 | 26,098 (0%) | 0% | 105.9 | 1,899,487 | Common Stock |
| AN2 Therapeutics Inc | Joshua M. Eizen | See Remarks | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 05 Jan 2026 | 17,923 | 159,430 | - | 1.0 | 17,948 | Common Stock |
| Spok Holdings Inc | Vincent D. Kelly | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.19 per share. | 05 Jan 2026 | 17,539 | 122,708 (0%) | 0% | 13.2 | 231,339 | Common Stock |
| PB Bankshares Inc | Thomas R. Greenfield | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 0 | - | - | Common Stock | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 99,233 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 72,630 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 59,634 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 58,117 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 83,388 | - | 0 | Class A Common Stock | |
| 10x Genomics Inc (Class A) | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 17,463 | 0 | - | - | Stock Option (right to buy) | |
| H&R Block Inc | Curtis A. Campbell | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,216 | 42,821 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Paul Andrew Moore | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 17,168 | 40,501 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Paul Andrew Moore | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 17,168 | 0 | - | - | Restricted Stock Unit | |
| PENN Entertainment Inc | Carlos A. Ruisanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 16,835 | 32,810 (0%) | 0% | 0 | Common Stock | |
| PENN Entertainment Inc | Jane Scaccetti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 16,835 | 109,153 (0%) | 0% | 0 | Common Stock | |
| PENN Entertainment Inc | Johnny Hartnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 16,835 | 16,835 (0%) | 0% | 0 | Common Stock | |
| Connexa Sports Tech Inc | Hongyu Zhou | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 05 Jan 2026 | 16,830 | 179,382 | - | 1 | 16,830 | Common Stock |
| DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.16 per share. | 05 Jan 2026 | 16,667 | 18,167 | - | 7.2 | 119,336 | Class A Common Stock |
| DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 16,667 | 1,184,139 | - | - | Stock Option (right to buy) | |
| DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 05 Jan 2026 | 16,667 | 1,500 | - | 230 | 3,833,410 | Class A Common Stock |
| Idex Corp | Sean M. Gillen | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 16,595 | 16,595 (0%) | 0% | 0 | COMMON STOCK | |
| Mission Produce Inc | Joanne C. Wu | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 16,421 | 74,298 | - | 0 | COMMON STOCK | |
| ServiceTitan Inc (Class A) | Vahe Kuzoyan | Director, President | 05 Jan 2026 | 16,388 | 16,388 | - | 0 | Class A Common Stock | ||
| ServiceTitan Inc (Class A) | Vahe Kuzoyan | Director, President | 05 Jan 2026 | 16,388 | 16,388 | - | 0 | Class A Common Stock | ||
| ServiceTitan Inc (Class A) | Vahe Kuzoyan | Director, President | 05 Jan 2026 | 16,388 | 3,404,543 | - | - | Class B Common Stock | ||
| ServiceTitan Inc (Class A) | Vahe Kuzoyan | Director, President | 05 Jan 2026 | 16,388 | 3,388,155 | - | - | Class B Common Stock | ||
| Spok Holdings Inc | Vincent D. Kelly | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 16,280 | 0 | - | - | Restricted Stock Unit | |
| Ecovyst Inc | Kurt J. Bitting | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 05 Jan 2026 | 16,097 | 585,904 (0%) | 0% | 9.8 | 157,751 | Common Stock |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.08 per share. | 05 Jan 2026 | 16,021 | 389,623 (0%) | 0% | 121.1 | 1,939,823 | Common Stock, par value $0.10 per share |
| International Seaways Inc | Jeffrey D. Pribor | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.21 per share. | 05 Jan 2026 | 16,000 | 91,242 (0%) | 0% | 17.2 | 275,360 | Common Stock, no par value per share |
| International Seaways Inc | Jeffrey D. Pribor | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 16,000 | 15,289 | - | - | Stock Option (Right to Buy) | |
| Cleveland-Cliffs Inc | Keith A. Koci | EVP & President, CC Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 05 Jan 2026 | 15,947 | 527,528 (0%) | 0% | 13.2 | 210,500 | Common Shares |
| SSR Mining Inc | Joanne Thomopoulos | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,873 | 15,873 | - | - | Performance Share Units | |
| SSR Mining Inc | Joanne Thomopoulos | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,873 | 105,289 (0%) | 0% | 0 | Common Shares | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 101.70 per share. | 05 Jan 2026 | 15,634 | 34,203 (0%) | 0% | 101.7 | 1,589,978 | Common Stock |
| Capricor Therapeutics Inc | David B. Musket | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,500 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | George W. Dunbar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,500 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,500 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,500 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Paul Gisbert Auwaerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,500 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Michael Kelliher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,500 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Equity Bancshares Inc (Class A) | David E. Pass | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,475 | 15,475 | - | - | Stock Option (Right to Buy) |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.